Clinical trial

Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC

NCT04631770

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-05-01

PhaseNA

Study timeline

Study start (actual)2022-05-01Date precision: day

Registry last updated2023-09-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Neoplasmsverified · MONDO: lung neoplasm

Lymph Node Excisionunresolved

Interventions

Systemic mediastinal lymph node dissectionPROCEDURE

Spared mediastinal lymph node dissectionPROCEDURE

Sponsors & collaborators

Tianjin Medical University Cancer Institute and Hospitallead sponsor

Mapped research locations

TianjinTianjin Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04631770 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.